935106861
info@markelab.com
Precio
387.5€ (100 µg)
Tocilizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL-6R, Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis.
Biosimilars
Human
Monoclonal
Human
IL-6R
Human
IgG1
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 375823-41-9
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más